Literature DB >> 10602514

Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles.

P R Gavine1, J C Neil, D H Crouch.   

Abstract

Myc is overexpressed in many cancers as a result of gene rearrangement or amplification, but coding sequence changes which cluster in the N-terminal transactivation domain also appear to play a role in tumour progression. The prototypic v-Myc gene of MC29 virus differs from avian c-Myc by a series of mutations, including a change at a regulatory phosphorylation site within the mutational hotspot (thr-61) which is known to potentiate transformation in vitro. We now show that the mutation at thr-61 stabilizes the v-Myc protein (turnover difference) and that this single mutation is both necessary and sufficient for the phenotype. A major involvement of the proteasome in Myc degradation was confirmed, but surprisingly, a dilysine motif adjacent to thr-61 proved not to be the ubiquitin target. Two other v-Myc genes which carry a mutation at thr-61 (avian MH2) or a large deletion encompassing this domain (feline T17) were found to be stabilized to a similar extent as MC29, showing that stabilization is a common feature of independently derived Myc oncogenes. These results suggest a common selective process in the genesis of these three viral oncoproteins and a mechanistic link with Jun, Fos and Myb oncoproteins which are also stabilized relative to their cellular counterparts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602514     DOI: 10.1038/sj.onc.1203102

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

1.  A novel form of the RelA nuclear factor kappaB subunit is induced by and forms a complex with the proto-oncogene c-Myc.

Authors:  Neil R Chapman; Gill A Webster; Peter J Gillespie; Brian J Wilson; Dorothy H Crouch; Neil D Perkins
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

2.  The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.

Authors:  Markus Welcker; Amir Orian; Jianping Jin; Jonathan E Grim; Jonathan A Grim; J Wade Harper; Robert N Eisenman; Bruce E Clurman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

3.  Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.

Authors:  D H Crouch; F Fisher; S A La Rocca; C R Goding; D A F Gillespie
Journal:  Nucleic Acids Res       Date:  2005-09-15       Impact factor: 16.971

4.  Inactivation of MAP kinase signalling in Myc transformed cells and rescue by LiCl inhibition of GSK3.

Authors:  Osama Al-Assar; Dorothy H Crouch
Journal:  Mol Cancer       Date:  2005-04-05       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.